In embolic stroke of undetermined source, rivaroxaban vs aspirin did not reduce recurrence and increased bleeding

Autor:	Richard W Frieden
Rok vydání:	2018
Předmět:	Rivaroxaban medicine.medical_specialty Aspirin business.industry MEDLINE Hemorrhage General Medicine medicine.disease Embolic stroke Stroke Stroke prevention Internal medicine Internal Medicine medicine Cardiology Humans business medicine.drug
Zdroj:	Annals of Internal Medicine. 169:JC32
ISSN:	0003-4819
Popis:	Source Citation Hart RG, Sharma M, Mundl H, et al; NAVIGATE ESUS Investigators. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378:2191-201. 29766772
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7986c1714c0cdd42fff22b19d3a81936 https://doi.org/10.7326/acpjc-2018-169-6-032 Zobrazit plný text záznamu